Atlas Trials

Use of Regorafenib in Recurrent Epithelial Ovarian Cancer

Clinical trial NCT02736305 · COMPLETED

Trial details

NCT number
NCT02736305
Sponsor
National Cancer Centre, Singapore
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Neoplasms
Start date
2016-02-03
Primary completion
2019-11-18
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.